TryGOLD- Free

Moderna Shares Slide As Weak Sales Bring Big Cut in Guidance
The Wall Street Journal|January 14, 2025
Moderna shares plunged 17% Monday after the vaccine maker slashed its forecast of full-year 2025 revenue, as sales of its vaccines against Covid-19 and respiratory syncytial virus continue to be sluggish.
- PETER LOFTUS
Moderna Shares Slide As Weak Sales Bring Big Cut in Guidance

This story is from the January 14, 2025 edition of The Wall Street Journal.

Start your 7-day Magzter GOLD free trial to access thousands of curated premium stories, and 9,000+ magazines and newspapers.

Moderna Shares Slide As Weak Sales Bring Big Cut in Guidance
Gold Icon

This story is from the January 14, 2025 edition of The Wall Street Journal.

Start your 7-day Magzter GOLD free trial to access thousands of curated premium stories, and 9,000+ magazines and newspapers.

We use cookies to provide and improve our services. By using our site, you consent to cookies. Learn more